Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands		Preferred Stock [Member] Series D Preferred Stock [Member]	Preferred Stock [Member] Series E Preferred Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Common Stock [Member]	Total
Balance at Dec. 31, 2023		$ 0	$ 0			$ 118,928	$ (78,854)	$ 98	$ 40,172
Balance (in Shares) at Dec. 31, 2023		20,627	20,000					9,826,719
Conversion of Series D Preferred Stock		$ 0	$ 0			(2)	0	$ 2	0
Issuance of Common Stock upon warrant exercise		0	0			4,454	0	$ 7	4,461
Issuance of Common Stock upon warrant exercise (in Shares)								743,610
Stock–based compensation		0	0			2,067	0	$ 0	2,067
Net income (loss)		0	0			0	(9,037)	0	(9,037)
Balance at Mar. 31, 2024		$ 0	$ 0			125,447	(87,891)	$ 107	37,663
Balance (in Shares) at Mar. 31, 2024		19,402	20,000					10,815,329
Balance at Dec. 31, 2023		$ 0	$ 0			118,928	(78,854)	$ 98	40,172
Balance (in Shares) at Dec. 31, 2023		20,627	20,000					9,826,719
Balance at Jun. 30, 2024		$ 0	$ 0			131,830	(96,405)	$ 124	35,549
Balance (in Shares) at Jun. 30, 2024		16,507	20,000					12,564,861
Balance at Dec. 31, 2023		$ 0	$ 0			118,928	(78,854)	$ 98	40,172
Balance (in Shares) at Dec. 31, 2023		20,627	20,000					9,826,719
Issuance of Common Stock related to stock–based compensation	[1]								600
Series F Preferred Stock declared dividends									0
Remeasurement of Series F preferred stock									0
Net income (loss)									(28,975)
Balance at Sep. 30, 2024		$ 0	$ 0			168,887	(107,829)	$ 227	61,285
Balance (in Shares) at Sep. 30, 2024		14,457	0					22,918,763
Balance at Dec. 31, 2023		$ 0	$ 0			118,928	(78,854)	$ 98	40,172
Balance (in Shares) at Dec. 31, 2023		20,627	20,000					9,826,719
Balance at Dec. 31, 2024		$ 0		$ 230	$ 0	172,304	(119,766)		$ 52,768
Balance (in Shares) at Dec. 31, 2024		14,457		23,045,209
Balance (in Shares) at Dec. 31, 2024					0				0
Conversion of Series D Preferred Stock (in Shares)		(1,225)						245,000
Balance at Mar. 31, 2024		$ 0	$ 0			125,447	(87,891)	$ 107	$ 37,663
Balance (in Shares) at Mar. 31, 2024		19,402	20,000					10,815,329
Conversion of Series D Preferred Stock		$ 0	$ 0			(6)	0	$ 6	0
Issuance of Common Stock upon warrant exercise		0	0			5,008	0	$ 8	5,016
Issuance of Common Stock upon warrant exercise (in Shares)								836,130
Issuance of Common Stock related to stock–based compensation		0	0			(3)	0	$ 3	0
Issuance of Common Stock related to stock–based compensation (in Shares)								334,312
Stock–based compensation		0	0			1,384	0	$ 0	1,384
Net income (loss)		0	0			0	(8,514)	0	(8,514)
Balance at Jun. 30, 2024		$ 0	$ 0			131,830	(96,405)	$ 124	35,549
Balance (in Shares) at Jun. 30, 2024		16,507	20,000					12,564,861
Conversion of Series D Preferred Stock (in Shares)		(2,895)						579,090
Conversion of Series D Preferred Stock		$ 0	$ 0			(4)	0	$ 4	0
Conversion of Series E Preferred Stock		0	$ 0			(40)	0	$ 40	0
Conversion of Series E Preferred Stock (in Shares)			(20,000)					4,000,000
Issuance of Common Stock upon warrant exercise		0	$ 0			24,020	0	$ 40	24,060
Issuance of Common Stock upon warrant exercise (in Shares)								4,010,000
Issuance of Common Stock to fund NRO Acquisition, net of issuance costs		0	0			10,097	0	$ 18	10,115
Issuance of Common Stock to fund NRO Acquisition, net of issuance costs (in Shares)								1,827,040
Issuance of Common Stock for SEPA commitment fee		0	0			599	0	$ 1	600
Issuance of Common Stock for SEPA commitment fee (in Shares)								100,000
Issuance of Common Stock related to stock–based compensation		0	0			0	0	$ 0	0
Issuance of Common Stock related to stock–based compensation (in Shares)								6,862
Stock–based compensation		0	0			2,385	0	$ 0	2,385
Series F Preferred Stock declared dividends									0
Remeasurement of Series F preferred stock									0
Net income (loss)		0	0			0	(11,424)	0	(11,424)
Balance at Sep. 30, 2024		$ 0	$ 0			168,887	(107,829)	$ 227	61,285
Balance (in Shares) at Sep. 30, 2024		14,457	0					22,918,763
Conversion of Series D Preferred Stock (in Shares)		(2,050)						410,000
Balance at Dec. 31, 2024		$ 0		$ 230	$ 0	172,304	(119,766)		52,768
Balance (in Shares) at Dec. 31, 2024		14,457		23,045,209
Conversion of Series D Preferred Stock		$ 0		$ 17	0	(17)	0		0
Conversion of Series F Preferred Stock		0		$ 3	0	1,348	0		1,351
Conversion of Series F Preferred Stock (in Shares)				252,000
Issuance of Common Stock upon option exercise		0		$ 23	0	560	0		583
Issuance of Common Stock upon option exercise (in Shares)				2,333,334
Issuance of Common Stock upon Senior Convertible Note conversion		0		$ 21	0	18,143	0		18,164
Issuance of Common Stock upon Senior Convertible Note conversion (in Shares)				2,118,862
Issuance of Common Stock to fund Bayswater Acquisition, net of issuance costs		0		$ 97	0	37,565	0		37,662
Issuance of Common Stock to fund Bayswater Acquisition, net of issuance costs (in Shares)				9,736,904
Issuance of common stock to seller as part of Bayswater Acquisition		0		$ 37	0	15,963	0		16,000
Issuance of common stock to seller as part of Bayswater Acquisition (in Shares)				3,656,099
Issuance of Common Stock related to stock–based compensation		0		$ 1	0	(1)	0		0
Issuance of Common Stock related to stock–based compensation (in Shares)				144,915
Purchase of treasury stock		0		$ 0	$ (336)	0	0		(336)
Purchase of treasury stock (in Shares)				(40,196)	40,196
Stock–based compensation		0		$ 0	$ 0	1,324	0		1,324
Series F Preferred Stock undeclared dividends		0		0	0	(245)	0		(245)
Series F Preferred Stock deemed dividends		0		0	0	(90,612)	0		(90,612)
Net income (loss)		0		0	0	0	(2,617)		(2,617)
Balance at Mar. 31, 2025		$ 0		$ 429	$ (336)	156,332	(122,383)		34,042
Balance (in Shares) at Mar. 31, 2025		5,982		42,942,127
Balance (in Shares) at Mar. 31, 2025					40,196
Balance at Dec. 31, 2024		$ 0		$ 230	$ 0	172,304	(119,766)		$ 52,768
Balance (in Shares) at Dec. 31, 2024		14,457		23,045,209
Balance (in Shares) at Dec. 31, 2024					0				0
Issuance of Common Stock related to stock–based compensation	[1]								$ 0
Series F Preferred Stock declared dividends									(7,540)
Remeasurement of Series F preferred stock									(93,087)
Net income (loss)									34,353
Balance at Sep. 30, 2025		$ 0		$ 540	$ (442)	187,152	(85,413)		$ 101,837
Balance (in Shares) at Sep. 30, 2025		5,982		54,012,410
Balance (in Shares) at Sep. 30, 2025					63,337				63,337
Conversion of Series D Preferred Stock (in Shares)		(8,475)		1,695,000
Balance at Mar. 31, 2025		$ 0		$ 429	$ (336)	156,332	(122,383)		$ 34,042
Balance (in Shares) at Mar. 31, 2025		5,982		42,942,127
Balance (in Shares) at Mar. 31, 2025					40,196
Conversion of Series F Preferred Stock		$ 0		$ 8	$ 0	3,413	0		3,421
Conversion of Series F Preferred Stock (in Shares)				774,000
Issuance of Common Stock for Series F Preferred Stock dividends		0		$ 13	0	3,276	0		3,289
Issuance of Common Stock for Series F Preferred Stock dividends (in Shares)				1,305,000
Issuance of Common Stock upon option exercise		0		$ 5	0	45	0		50
Issuance of Common Stock upon option exercise (in Shares)				483,870
Issuance of Common Stock related to stock–based compensation		0		$ 1	0	(1)	0		0
Issuance of Common Stock related to stock–based compensation (in Shares)				130,619
Purchase of treasury stock		0		$ 0	$ (82)	0	0		(82)
Purchase of treasury stock (in Shares)				(17,049)	17,049
Stock–based compensation		0		$ 0	$ 0	2,398	0		2,398
Reclassification of Common Stock issuance costs		0		0	0	2,552	0		2,552
Series F Preferred Stock declared dividends		0		0	0	(3,289)	0		(3,289)
Series F Preferred Stock undeclared dividends		0		0	0	(1,402)	0		(1,402)
Remeasurement of Series F preferred stock		0		0	0	17,511	0		17,511
Net income (loss)		0		0	0	0	35,683		35,683
Balance at Jun. 30, 2025		$ 0		$ 456	$ (418)	180,835	(86,700)		94,173
Balance (in Shares) at Jun. 30, 2025		5,982		45,618,567
Balance (in Shares) at Jun. 30, 2025					57,245
Conversion of Series F Preferred Stock		$ 0		$ 64	$ 0	22,312	0		22,376
Conversion of Series F Preferred Stock (in Shares)				6,364,000
Issuance of Common Stock for Series F Preferred Stock dividends		0		$ 18	0	3,933	0		3,951
Issuance of Common Stock for Series F Preferred Stock dividends (in Shares)				1,806,000
Issuance of Common Stock upon option exercise		0		$ 2	0	(2)	0		0
Issuance of Common Stock upon option exercise (in Shares)				176,637
Issuance of Common Stock related to stock–based compensation		0		$ 0	0	0	0		0
Issuance of Common Stock related to stock–based compensation (in Shares)				53,298
Purchase of treasury stock		0		$ 0	$ (24)	0	0		(24)
Purchase of treasury stock (in Shares)				(6,092)	6,092
Stock–based compensation		0		$ 0	$ 0	4,123	0		4,123
Common Stock issuance costs		0		0	0	(254)	0		(254)
Series F Preferred Stock declared dividends		0		0	0	(4,252)	0		(4,252)
Series F Preferred Stock undeclared dividends		0		0	0	443	0		443
Remeasurement of Series F preferred stock		0		0	0	(19,986)	0		(19,986)
Net income (loss)		0		0	0	0	1,287		1,287
Balance at Sep. 30, 2025		$ 0		$ 540	$ (442)	$ 187,152	$ (85,413)		$ 101,837
Balance (in Shares) at Sep. 30, 2025		5,982		54,012,410
Balance (in Shares) at Sep. 30, 2025					63,337				63,337

[1] Pursuant to the Standby Equity Purchase Agreement (the “SEPA”), the Company issued 100,000 shares to YA II PN, LTD., a Cayman Islands exempt limited company (“Yorkville”) as a commitment fee. Refer to Note 10 – Debt for a discussion of the SEPA.